carismatx.com (CARM): Market Value
Carisma Therapeutics (CARM) is developing a unique cellular cancer treatment system by creating a closed network of medical protocols through macrophage modification. Partnerships with global pharmaceutical behemoths are accelerating the search for methods to combat severe tumors. This daily price chart illustrates a market capitalization of 0.01. Stringent FDA requirements and patent protection for its technologies establish a robust defensive barrier against new market entrants.
Comprehensive metric breakdowns and analytics for Carisma Therapeutics Inc. (CARM)
- current price and projected stock value:
- stock exchange capitalization data:
- book value of equity indicators:
- debt and solvency information:
Total Debt to Capital Carisma Therapeutics|CARM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Carisma Therapeutics Inc|CARM - Company Aggregate Debts|Debt to Book Capitalization Ratio Carisma Therapeutics Inc|CARM - Company Long-Term Loans and Borrowings|Company Short-Term Debt Carisma Therapeutics|Quick Ratio carismatx.com
- business earnings and investment ratios data:
CARM - Net Profit|Future Profit Carisma Therapeutics|CARM - Company Value to Net Income|Forward P/E Multiple carismatx.com|CARM - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|CARM - Operating profit before deduction of amortization|Earnings per share for the last twelve months Carisma Therapeutics|CARM - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months carismatx.com|CARM - Earnings growth in current year|Net earnings per share growth forecast for next year Carisma Therapeutics
- sales and revenue data:
Fundamental company analysis:CARM (Carisma Therapeutics Inc.)
The market capitalization of Carisma Therapeutics (CARM) reflects the aggregate value of its shares, which depends on market expectations regarding the company's operational success. This metric allows for an assessment of the current equity value of the business, accounting for all macroeconomic risks. The sustainability of R&D programs is supported by a macrophage patent platform and partnerships with biopharma behemoths. Analyzing changes in the company's market capitalization helps identify entry points, while chart extremes signal either stagnation risks or growth potential.
Key competitors
Market Value Argenx ARGX|BNTX: Market Capitalization|ABVX: Market Valuation|ADMA Biologics (ADMA) - Market Valuation|PTGX (Protagonist Therapeutics Inc) - Market Valuation|IMVT: Market Value|Market Value Kiniksa|Grifols Group - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Therapeutics) - Market Value|Market Capitalization AUPH (auriniapharma.com)|Market Capitalization BioCryst Pharmaceuticals, Inc. BCRX|VERA - Market Value|Market Value DNTH (Dianthus Corp)|pharvaris.com (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc|TRML (tourmalinebio.com) - Market Capitalization|Market Capitalization Intrexon|Market Valuation PHAR (Pharming)|NKTR (Nektar) - Market Value|Market Value upstreambio.com UPB|Market Capitalization zenasbio.com (ZBIO)|IMNM - Market Value|Gossamer Bio Inc (GOSS) - Market Valuation|KalVista Corp (KALV) - Market Value|Market Valuation Septerna Inc|Market Valuation PVLA|Market Capitalization savarapharma.com|Market Value Rigel Pharmaceuticals Inc (RIGL)|AnaptysBio - Market Capitalization|Market Capitalization ATXS (astriatx.com)|enGene Bio (ENGN) - Market Value|RAPT - Market Value|JBIO - Market Capitalization|ACRS: Market Capitalization|Market Value Kyverna (KYTX)|Market Valuation TLSA|Market Value CABA|Market Valuation VTYX (Ventyx Bio)|THTX (Theratechnologies Inc.) - Market Value|Market Value Avalo Therapeutics Inc AVTX|Eledon Pharmaceuticals Inc. (ELDN) - Market Value|AGEN - Market Value|Market Value CLYM (Climb Bio, Inc.)|ZURA: Market Capitalization|aTyr Pharma, Inc. - Market Value|ADAG (Adagene Corp) - Market Capitalization|ikenaoncology.com (IMA) - Market Capitalization|Market Valuation STTK (Shattuck Labs Inc)|Market Capitalization Equillium Inc|Market Capitalization CNTB (connectbiopharm.com)|IMUX: Market Capitalization|Atara Bio - Market Capitalization|IFRX: Market Value|XFOR: Market Capitalization|Market Valuation Adicet Bio Inc.|Market Value Celularity|Market Capitalization INMB (INmune Bio, Inc.)|Market Valuation BRNS (Barinthus Biotherapeutics)|KZR - Market Value|SAB Biotherapeutics Inc. - Market Valuation|Market Value AKTX (Akari Therapeutics plc)|ENLV: Market Valuation|Market Valuation QTTB|GOVX: Market Capitalization|Market Valuation Edesa|Market Value iBio Corporation|XTL Biopharmaceuticals, Ltd. (XTLB) - Market Capitalization|Market Capitalization BOLT|HCWB (HCW Biologics) - Market Value|Market Capitalization APVO (Aptevo Therapeutics, Inc.)|Market Value AIM|ADTX: Market Valuation|Market Value GRI (GRI Bio Corp)|XRTX: Market Capitalization|Market Capitalization HIND|Market Value Revelation Biosciences, Inc.|Market Capitalization INDP (Indaptus Therapeutics, Inc.)|Market Capitalization SCNI|CALI (CalciMedica Inc) - Market Value|Market Capitalization AFMD (Affimed NV)|ALLK - Market Valuation|HOOKIPA Pharma Inc. - Market Capitalization|Market Value IGMS (igmbio.com)|iTeos Pharma (ITOS) - Market Value|Ocean Bio - Market Value|TCBP (TC BioPharm (Holdings) Plc) - Market Capitalization|Market Capitalization Third Harmonic Bio, Inc.
